Literature DB >> 24489429

Oxidative Reactivity and Cytotoxic Properties of a Platinum(II) Complex Prepared by Outer-Sphere Amide Bond Coupling.

Justin J Wilson1, Stephen J Lippard1.   

Abstract

class="Chemical">Benzyl amine was coupled to the dangling n class="Chemical">carboxylic acid groups of the platinum(II) complex [Pt(edda)Cl2], where edda = ethylenediamine-N,N'-diacetic acid, to give the diamidetethered complex [Pt(L)Cl2] (1), where L = ethylenediamine-N,N'-bis(N-benzylacetamide). Complex 1 was oxidized with both PhICl2 and Br2. Oxidation with PhICl2 cleanly afforded the tetrachloride complex, [Pt(L)Cl4] (2), whereas oxidation with Br2 gave rise to several mixed halide complexes of the general formula, [Pt(L)ClxBr4-x], where x = 1, 2, or 3. Complexes 1 and 2 were fully characterized by 1H, 13C, and 195Pt NMR spectroscopy, as well as by ESI-MS. These compounds exist as a mixture of diastereomers that arise from the chirality of the two coordinated nitrogen atoms. Crystal structures of 1, 2, and [Pt(L)ClxBry] (3) are reported. Although refined as the tetrabromide complex [Pt(L)Br4], the crystal structure of 3 is a mixture of species with site-occupancy disorder of chloride and bromide ligands. DFT calculations indicate that the two sets of diastereomers of 1 and 2 are effectively thermoneutral, a conclusion that is also supported by the observation of both members of each pair by NMR spectroscopy. The cytotoxicity of 1 and 2 was measured by the MTT assay in HeLa cells and compared to that of cisplatin. Both exhibit IC50 values close to 50 μM and are therefore substantially less toxic than cisplatin, for which the IC50 is 1 μM.

Entities:  

Keywords:  MTT assay; NMR spectroscopy; X-ray crystallography; amide coupling; cisplatin; platinum

Year:  2013        PMID: 24489429      PMCID: PMC3905621          DOI: 10.1016/j.poly.2012.07.097

Source DB:  PubMed          Journal:  Polyhedron        ISSN: 0277-5387            Impact factor:   3.052


  36 in total

1.  Activity of some platinum(II/IV) complexes with O,O-n-butyl-and O,O-n-pentyl-ethylenediamine-N,N'-di-3-propanoate and halogeno ligands against HeLa and K562 cell lines and human PBMC.

Authors:  Goran N Kaluderović; Vesna M Dinović; Zorica D Juranić; Tatjana P Stanojković; Tibor J Sabo
Journal:  J Inorg Biochem       Date:  2005-02       Impact factor: 4.155

2.  Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(IV)-peptide bioconjugates.

Authors:  Luca Gaviglio; Annika Gross; Nils Metzler-Nolte; Mauro Ravera
Journal:  Metallomics       Date:  2012-02-07       Impact factor: 4.526

3.  Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting.

Authors:  Katherine S Lovejoy; Stephen J Lippard
Journal:  Dalton Trans       Date:  2009-10-01       Impact factor: 4.390

4.  Kinetics and mechanism for reduction of anticancer-active tetrachloroam(m)ine platinum(IV) compounds by glutathione.

Authors:  K Lemma; J Berglund; N Farrell; L I Elding
Journal:  J Biol Inorg Chem       Date:  2000-06       Impact factor: 3.358

5.  Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.

Authors:  Jelena M Lazić; Ljubica Vucićević; Sanja Grgurić-Sipka; Kristina Janjetović; Goran N Kaluderović; Maja Misirkić; Maja Gruden-Pavlović; Dusan Popadić; Reinhard Paschke; Vladimir Trajković; Tibor J Sabo
Journal:  ChemMedChem       Date:  2010-06-07       Impact factor: 3.466

6.  Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads.

Authors:  Shanta Dhar; Weston L Daniel; David A Giljohann; Chad A Mirkin; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2009-10-21       Impact factor: 15.419

7.  Modulation of Ligand Fluorescence by the Pt(II)/Pt(IV) Redox Couple.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Inorganica Chim Acta       Date:  2012-01-03       Impact factor: 2.545

Review 8.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

9.  Postsynthetic modifications of iron-carboxylate nanoscale metal-organic frameworks for imaging and drug delivery.

Authors:  Kathryn M L Taylor-Pashow; Joseph Della Rocca; Zhigang Xie; Sylvie Tran; Wenbin Lin
Journal:  J Am Chem Soc       Date:  2009-10-14       Impact factor: 15.419

10.  Novel di- and tetracarboxylatoplatinum(IV) complexes. Synthesis, characterization, cytotoxic activity, and DNA platination.

Authors:  Michael R Reithofer; Seied M Valiahdi; Michael A Jakupec; Vladimir B Arion; Alexander Egger; Mathea Sophia Galanski; Bernhard K Keppler
Journal:  J Med Chem       Date:  2007-11-22       Impact factor: 7.446

View more
  2 in total

1.  Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugs.

Authors:  Timothy C Johnstone; Sarah M Alexander; Justin J Wilson; Stephen J Lippard
Journal:  Dalton Trans       Date:  2015-01-07       Impact factor: 4.390

Review 2.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.